Authors
Latest:
Prescribing Patterns: How to Get Ahead of the TrendsThe key to success in a hypercompetitive marketplace is to create targeting plans that get ahead of tomorrow’s prescriptions.
Latest:
Towards a Multichannel Marketing CultureThe biggest challenge to becoming a multi-channel marketing organization is not a company's technology, it’s the culture, write Melissa Dimitri, Larry Smith, Laurel Fitts, and Mark Trybulski.
Latest:
The Brexit Deal and the Life Sciences SectorOn December 24, 2020, the UK finally agreed a Trade and Cooperation Agreement (TCA) with the EU. Cliodhna McDonough offers some initial thoughts on the implications of the TCA on the life sciences sector.
Latest:
Transforming the CIO Role to Embrace Digital HealthStrategies for those chief information officers taking the digital reins at their organizations.
Latest:
Forget Selecting a Site — Now the Site Selects YouPost-approval studies, at many companies, do not have a consistent strategy that builds networks of investigators.
Latest:
Commercializing an Orphan Drug: Why “Just” Serving a High Unmet Medical Need Won’t Do the JobLooking at four building blocks of success, Wolfram Lux and Simone Seiter investigate what it takes to win and be successful when commercializing an orphan drug
Latest:
A Contingent Workforce Strategy Is Critical to Life Sciences CompaniesSpeed to market is crucial to the success of launching new products and therapies.
Latest:
Pharma Pulse 11/21/24: A Global Standard for Data Sources, 75% of Adults are Obese & moreThe latest news for pharma industry insiders.
Latest:
How UCB Transformed into a More Agile, Data-Driven OrganizationAnita Moser, Michael Davis, Dharmendra Sahay outline UCB's measured approach to scaling its AI capabilities.
Latest:
Lean Thinking in Life Sciences: A Case for Enabling PeopleFully understanding the construct of what it means to be lean can equip individual contributors, teams, and leaders to contribute to the fullest extent of their capabilities.
Latest:
What You Need to Know about the Drug Supply Chain Security ActIt is vital to begin asking questions about your company’s DSCSA readiness and compliance, as well as that of your strategic partners, writes Rob Besse.
Latest:
Leading Teams through the COVID-19 CrisisSuzanne Bates offers advice for leaders who are steering their teams through the current health crisis.
Latest:
Digital UpskillingArchaic ways of working need to make way for more agile and nimble response mechanisms enabled by a systematic enterprise-wide digital upskilling strategy, writes Anand Kiran.
Latest:
Design Thinking in Multichannel MarketingWhile marketers must work with less than perfect insight when devising their channel strategies, they can improve their success rate by applying Design Thinking, write Ilya Vedrashko and Parag More.
Latest:
COVID-19 Highlights Need for More Agility, New Paradigms in Drug DevelopmentThe rapid spread of COVID-19 across the globe highlights the absolute need for preparedness in the face of pandemics in order to reduce and eliminate the emergence of new cases and quickly create treatment options for emerging illnesses and diseases.
Latest:
How Medical Affairs Teams Need to Adapt to COVID-19COVID-19 will cause acute strain on medical affairs in the short term, but longer-term planning is also needed to ensure that teams can remain in the more visible role that customers are demanding, writes Sarah Jarvis.
Latest:
Patient Experience Breakthroughs: Leveraging the Latest Digital Tools and Techniques to Optimize your Patient Experience GoalsLearn how breakthrough patient experience strategies can help achieve your study goals in this upcoming webcast. Lead by renowned neuroscientist and behavioral economist Dr. Paul Glimcher, it’s the one webcast this year your team can’t afford to miss. Live: Tuesday, May 19, 2020 at 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until May 19, 2021. Register free
Latest:
Solving Access Challenges in Today’s MarketNew drug launches face more marketplace scrutiny today than a decade ago. Brand success requires not only communicating the clinical value to providers and patients, but also demonstrating the cost-effectiveness to payers in a real-world setting.
Latest:
Fight Against COVID-19 May Yield Solutions to ARDSCombating ARDS, the biggest threat to COVID-19 patients, may lead to new treatments for the condition, writes physician and biotech CEO Joe G. N. “Skip” Garcia.
Latest:
How Biosimilar Manufacturers Can Get the Most Out of the "Patent Cliff"As the number of biologics facing patent expiration in the US continues to rise, the market is further opening up to biosimilar manufacturers. George I'ons offers some pointers on how to secure an attractive market share during this time.
Latest:
COVID-19 Therapeutics and Vaccines Are Here: What All Companies Need to Do NextThe pharmaceutical industry must be prepared for the coming wave of COVID-related safety reports.
